GianlucaIacobellisMD PhD
Endocrinology • Miami, FLDiabetes, Lipid Metabolism, Obesity
Full Professor, Medicine, University of Miami Leonard M. Miller School of Medicine
Dr. Iacobellis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-243-4000- Is this information wrong?
Summary
- My clinical activity focuses on the contemporary treatment and prevention of diabetes and diabetes related cardiovascular complications.
My research pioneered the role of epicardial fat as new cardiovascular risk factor and therapeutic target.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2005
University of Texas Southwestern Medical CenterPost-Doctoral Fellowship, Endocrinology- clinical nutrition , 2004 - 2005
Sapienza University of RomeClass of 1994, MD, 110/110 cum laude
Certifications & Licensure
FL State Medical License 2010 - 2026
Awards, Honors, & Recognition
- Office of Research, Research Education and Innovative Medicine University of Miami, 2017
- Internal Career Award McMaster University, 2006
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Liraglutide Hospital Discharge Trial Start of enrollment: 2014 Mar 01
- Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes Start of enrollment: 2014 Mar 01
- Dapagliflozin Effects on Epicardial Fat Start of enrollment: 2015 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- BNT162b2 Booster Dose Elicits a Robust Antibody Response in Subjects with Abdominal Obesity and Previous SARS-CoV-2 Infection.Malavazos, A., Dubini, C., Milani, V., Boveri, S., Meregalli, C., Bertolini, C., Buscemi, C., Cardani, R., Renna, L., Trevisan, M., Scravaglieri, V., Cuppone, M., Meni...> ;Vaccines. 2023 Nov 30
- Epicardial fat thickness in type 2 diabetes outpatient care.Malavazos, A., Munoz Sterling, C., Iacobellis, G., Goldberger, J., Canturk, A.> ;Nutrition, Metabolism, and Cardiovascular Diseases. 2024 Mar 1
- 1 citationsComparison of Glycemic Control Between In-Person and Virtual Diabetes Consults in Hospitalized Patients With Diabetes.Maria Gracia Luzuriaga, Monica Lieberman, Ruixuan Ma, Sabina Casula, Violet Lagari-Libhaber, Shari Messinger, Hua Li, Bresta Miranda, David A Baidal, Ernesto Bernal Mi...> ;Journal of Diabetes Science and Technology. 2023 Sep 20
- Join now to see all
Press Mentions
NIH Grant Supports Innovative Multifaceted Heart StudyApril 27th, 2021- Can Epicardial Fat Glucagon-like Peptide-1 Receptor Open up to the Cardiovascular Benefits of Glucagon-like Peptide-1 Analogues?March 29th, 2021
- Researchers Look into Onset Diabetes Due to COVID-19February 3rd, 2021
- Join now to see all
Grant Support
- Liraglutide effects on epicardial fat inflammatory genes in diabetes and coronary artery diseaseNovo Nordisk2018–Present
- Effects of Dapagliflozin on Epicardial Fat in Subjects With Type 2 DiabetesAstra Zeneca2015–Present
- Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 DiabetesNovo Nordisk2014–Present
- Trans-omic analysis of epicardial adipose tissue in atrial fibrillationNIH2019–2023
- Liragultide effects on Atrial Fibrillation (LEAF)NIH2019–2022
Other Languages
- Italian, Spanish
Hospital Affiliations
UMHC-Sylvester Comprehensive Cancer CenterMiami, Florida
Jackson Health SystemMiami, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
